Medicare Enrolled
Dr. Jason Aldred, M.D.
Neurology · Spokane, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aldred from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aldred?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aldred
Dr. Jason Aldred is a neurology specialist in Spokane, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aldred performed 67,233 Medicare services across 2,250 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aldred received a total of $940,344 from 50 pharmaceutical and/or device companies across 1150 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aldred is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in WA
$940,344 industry payments
Medicare Practice Summary
Medicare Utilization ↗67,233
Medicare services
Top 1% in WA for neurology
2,250
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,539 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
32,222 | $4 | $10 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
22,376 | $5 | $13 |
| AbobotulinumtoxinA injection, 5 units An injection of abobotulinumtoxinA administered in a quantity of 5 units. |
5,700 | $6 | $17 |
| Rimabotulinumtoxinb injection, 100 units An injection of rimabotulinumtoxinb administered in a dose of 100 units. |
2,000 | $10 | $25 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,112 | $49 | $128 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
787 | $90 | $259 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
503 | $122 | $365 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
460 | $78 | $208 |
| Brain stimulator programming, first 15 minutes Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes. |
286 | $37 | $103 |
| Brain stimulator programming, additional 15 minutes Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service. |
232 | $33 | $89 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 208 | $62 | $167 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
134 | $37 | $97 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
126 | $132 | $277 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
122 | $90 | $235 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
120 | $163 | $445 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
116 | $41 | $121 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
114 | $95 | $249 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
107 | $53 | $210 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
92 | $186 | $518 |
| New patient office visit, complex (60-74 min) | 92 | $146 | $445 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
57 | $100 | $363 |
| Chemical paralysis of salivary glands, bilateral Injection of a chemical agent to paralyze the salivary glands on both sides of the mouth. |
49 | $92 | $262 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
49 | $125 | $276 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
46 | $122 | $370 |
| Chemical nerve block injection, 1-4 muscles An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated. |
30 | $115 | $308 |
| Psychiatric diagnostic evaluation A clinical assessment conducted by a psychiatrist to evaluate a patient's mental health status and determine a diagnosis. |
29 | $137 | $357 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
26 | $4 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $73 | $184 |
| Psychotherapy session, 1 hour A one-hour psychotherapy session involving talk therapy to address mental health concerns. |
13 | $101 | $301 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
11 | $336 | $931 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
93.5% medium
6.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$940,344
Total received (2018-2024)
Avg $134,335/year across 7 years
Top 1% in WA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,150
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$883,152 (93.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$53,008 (5.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,184 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$202,779
2023
$146,194
2022
$87,658
2021
$130,068
2020
$82,516
2019
$150,720
2018
$140,408
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$79,568
Teva Pharmaceuticals USA, Inc.
$65,130
Boston Scientific Corporation
$21,026
Neurocrine Biosciences, Inc.
$17,664
Merz Pharmaceuticals, LLC
$11,844
MDD US Operations, LLC
$4,399
Amneal Pharmaceuticals LLC
$2,772
Ipsen Biopharmaceuticals, Inc
$148
REVANCE THERAPEUTICS, INC.
$102
ACADIA Pharmaceuticals Inc
$53
ORPHALAN INC
$20
Lilly USA, LLC
$19
Cala Health, Inc.
$19
Kyowa Kirin, Inc.
$14
Top 3 companies account for 81.7% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$320,555
AbbVie Inc.
$117,873
ABBVIE INC.
$103,308
AbbVie, Inc.
$97,857
Acorda Therapeutics, Inc
$68,195
Boston Scientific Corporation
$48,130
Allergan, Inc.
$43,771
Neurocrine Biosciences, Inc.
$38,778
Allergan Inc.
$23,708
Sunovion Pharmaceuticals Inc.
$12,179
Merz Pharmaceuticals, LLC
$12,153
Biogen, Inc.
$11,475
Medtronic USA, Inc.
$8,899
Neurocrine BioSciences, Inc.
$8,480
Amneal Pharmaceuticals LLC
$5,763
Adamas Pharmaceuticals, Inc.
$5,691
MDD US Operations, LLC
$4,470
Kyowa Kirin, Inc.
$3,571
BOSTON SCIENTIFIC CORPORATION
$1,653
Abbott Laboratories
$894
US WorldMeds, LLC
$592
ACADIA Pharmaceuticals Inc
$345
Ipsen Biopharmaceuticals, Inc
$332
GENZYME CORPORATION
$261
Novartis Pharmaceuticals Corporation
$191
EMD Serono, Inc.
$158
GE HealthCare
$109
Medtronic, Inc.
$105
REVANCE THERAPEUTICS, INC.
$102
Merz North America, Inc.
$81
Lilly USA, LLC
$79
Mallinckrodt LLC
$73
Cala Health, Inc.
$71
Lundbeck LLC
$68
MERZ NORTH AMERICA, INC.
$51
Impax Laboratories, Inc.
$33
Amgen Inc.
$31
GE Healthcare
$30
GE HEALTHCARE
$26
Mitsubishi Tanabe Pharma America, Inc.
$25
Supernus Pharmaceuticals, Inc.
$21
Xeris Pharmaceuticals, Inc.
$21
ORPHALAN INC
$20
Zyla Life Sciences, Inc.
$20
InSightec,Inc
$20
Ultragenyx Pharmaceutical Inc.
$18
Biohaven Pharmaceuticals, Inc.
$16
GRT US Holding, Inc.
$16
Avanir Pharmaceuticals, Inc.
$14
Strongbridge US INC.
$13
Top 3 companies account for 57.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Bionic Navigator · CALA KIQ · CALA TRIO · CREXONT · CROSSBOSS · CUVRIOR · DAXXIFY · DUOPA · DYSPORT · Duopa · Dysport · EMGALITY · GENERAL DBS · GENERAL DBS · GENERAL THERAPIES · GENERAL - DBS · GENERAL DBS · GILENYA · GOCOVRI · General - DBS · Gocovri · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KEVEYIS · KYNMOBI · LEMTRADA · LUMIZYME · MAYZENT · MS DISEASE STATE · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · O-ARM-ST · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · Ongentys · PERCEPT PC BRAINSENSE · Proclaim Family of SCS IPGs · Qutenza · RYTARY · Radicava · Rebif · Repatha · SPECTRA WAVEWRITER · SPRIX · SYNCHROMED · TROKENDI XR · TYSABRI · UBRELVY · VERCISE · VUMERITY · VYALEV · VYEPTI · Vercise · XEOMIN · Xadago · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in WA.
Geographic Context
Neurologists within 10 mi
29
Per 100K population
5.3
County median income
$73,513
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aldred is a mixed practice specialist, with above-average Medicare volume (top 1% in WA), with speaking/promotional industry engagement in the top 1% of WA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aldred experienced with botox injection (xeomin), per unit?
Based on Medicare claims data, Dr. Aldred performed 32,222 botox injection (xeomin), per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aldred receive payments from pharmaceutical companies?
Yes. Dr. Aldred received a total of $940,344 from 50 companies across 1,150 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aldred's costs compare to other neurologists in Spokane?
Dr. Aldred's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aldred) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Spokane
Browse neurologists in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in WA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in WA
Which WA neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology